These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 25041782)
1. Epigenetic changes of TIMP-3, GSTP-1 and 14-3-3 sigma genes as indication of status of chronic inflammation and cancer. Wang YJ; He L; Yuan M; Tsang WW; Hao L; Wang M; Chow LW; Cheung MN; Liu Q; Ng EL; Loo WT; Chow CY; Bai LJ; Yang Z Int J Biol Markers; 2014 Sep; 29(3):e208-14. PubMed ID: 25041782 [TBL] [Abstract][Full Text] [Related]
2. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Pulukuri SM; Rao JS Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000 [TBL] [Abstract][Full Text] [Related]
3. Reversal of hypermethylation and reactivation of glutathione S-transferase pi 1 gene by curcumin in breast cancer cell line. Kumar U; Sharma U; Rathi G Tumour Biol; 2017 Feb; 39(2):1010428317692258. PubMed ID: 28222671 [TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of tumor suppressor genes BRCA1, p16 and 14-3-3sigma in serum of sporadic breast cancer patients. Jing F; Zhang J; Tao J; Zhou Y; Jun L; Tang X; Wang Y; Hai H Onkologie; 2007 Feb; 30(1-2):14-9. PubMed ID: 17264521 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells. Deb G; Thakur VS; Limaye AM; Gupta S Mol Carcinog; 2015 Jun; 54(6):485-99. PubMed ID: 24481780 [TBL] [Abstract][Full Text] [Related]
6. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis. Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic alterations are involved in the overexpression of glutathione S-transferase π-1 in human colorectal cancers. Zhang R; Kang KA; Piao MJ; Kim KC; Zheng J; Yao CW; Cha JW; Maeng YH; Chang WY; Moon PG; Baek MC; Hyun JW Int J Oncol; 2014 Sep; 45(3):1275-83. PubMed ID: 24970398 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic and proteolytic inactivation of 14-3-3sigma in breast and prostate cancers. Horie-Inoue K; Inoue S Semin Cancer Biol; 2006 Jun; 16(3):235-9. PubMed ID: 16682214 [TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas. Kunze E; Wendt M; Schlott T Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789 [TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance. Reibenwein J; Pils D; Horak P; Tomicek B; Goldner G; Worel N; Elandt K; Krainer M Prostate; 2007 Mar; 67(4):427-32. PubMed ID: 17192910 [TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation profile of 14-3-3 sigma and its reduced transcription/expression levels in Chinese sporadic female breast carcinogenesis. Luo J; Feng J; Lu J; Wang Y; Tang X; Xie F; Li W Med Oncol; 2010 Sep; 27(3):791-7. PubMed ID: 19685192 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic change in E-cadherin and COX-2 to predict chronic periodontitis. Loo WT; Jin L; Cheung MN; Wang M; Chow LW J Transl Med; 2010 Nov; 8():110. PubMed ID: 21047437 [TBL] [Abstract][Full Text] [Related]
15. Correlation of epigenetic change and identification of risk factors for oral submucous fibrosis. Xu C; Zhao J; Loo WT; Hao L; Wang M; Cheung MN; Dou Y; Yip AY; Ng EL; Chow LW; Liu Q Int J Biol Markers; 2012 Dec; 27(4):e314-21. PubMed ID: 23250779 [TBL] [Abstract][Full Text] [Related]
16. Promoter methylation and gene polymorphism are two independent events in regulation of GSTP1 gene expression. Bhat A; Masood A; Wani KA; Bhat YA; Nissar B; Khan NS; Ganai BA Tumour Biol; 2017 Apr; 39(4):1010428317697563. PubMed ID: 28443466 [TBL] [Abstract][Full Text] [Related]
18. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. Hoque MO; Feng Q; Toure P; Dem A; Critchlow CW; Hawes SE; Wood T; Jeronimo C; Rosenbaum E; Stern J; Yu M; Trink B; Kiviat NB; Sidransky D J Clin Oncol; 2006 Sep; 24(26):4262-9. PubMed ID: 16908936 [TBL] [Abstract][Full Text] [Related]
19. Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer. Spitzwieser M; Holzweber E; Pfeiler G; Hacker S; Cichna-Markl M Breast Cancer Res; 2015 Sep; 17(1):125. PubMed ID: 26370119 [TBL] [Abstract][Full Text] [Related]
20. Silencing Filamin A Inhibits the Invasion and Migration of Breast Cancer Cells by Up-regulating 14-3-3σ. Ji ZM; Yang LL; Ni J; Xu SP; Yang C; Duan P; Lou LP; Ruan QR Curr Med Sci; 2018 Jun; 38(3):461-466. PubMed ID: 30074213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]